Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

In Situ Engineering of Zwitterionic Betaine-Based Covalent Organic Frameworks Boost Cooperative CO2 Catalytic Conversion.

Created on 30 Aug 2025

Authors

Shiyuan Wei, Benling Yu, You Wang, Hao Wang, Meng Li, Jiawei Li, Jianhan Huang, You-Nian Liu

Published in

Small (Weinheim an der Bergstrasse, Germany). Pages e05352. Aug 30, 2025. Epub Aug 30, 2025.

Abstract

The development of a privileged organocatalyst featuring well-defined catalytic sites to drive highly cooperative CO2 conversion into high value-added fine chemicals is promising while challenging. Here in this work, three zwitterionic betaine-based covalent organic frameworks (COFs) bearing sulfonate, carboxylate, and phosphate moieties, namely, PS-TpBpy, BA-TpBpy, and PA-TpBpy, are in situ engineered through the post-synthetic quaternization of the bipyridine COF (TpBpy). Density functional theory-based Fukui function indicated that the pyridinium cation and the alkaline O anion in these betaine-based COFs serve as synergistic electrophilic and nucleophilic active sites, thus simultaneously activating o-phenylenediamine and CO2 for their highly efficient conversion to benzimidazole. Meanwhile, such assembly endows the catalysts with enhanced stability, alkalinity, and hydrophobic microenvironment, facilitating the fast enrichment of phenylsilane and CO2, and leading to largely enhanced reaction kinetic rates. In-depth mechanism investigations manifested that a cooperative double-catalytic cycle pathway is driven by the zwitterionic betaine-based COFs, which thermodynamically promote the carbamic acid formation and CO2 reduction processes, thereby improving the overall catalytic efficiency. This work highlights the rational construction of unique zwitterionic betaine-based COFs as the bifunctional organocatalysts to boost the highly cooperative CO2 catalytic conversion thermodynamically and kinetically.

PMID:
40884097
Bibliographic data and abstract were imported from PubMed on 30 Aug 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 34
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement